What is NAD?
NAD (Nicotinamide adenine dinucleotide) and its precursors, commonly known as NAD boosters, are some of the most important molecules on the planet—without them, life would cease to exist. At very high doses, they have been shown to improve the function of various types of cells and tissues throughout the aging body, including the heart, brain, muscles, and stem cells. Clinical studies show that one of the precursors, nicotinamide riboside, can increase NAD levels in white blood cells.
NAD can support cellular processes that contribute to healthy aging. A decline in its levels is not something the body tolerates well. In fact, several signs of aging are directly associated with the lack of NAD+ in the body, such as:
- Loss of proteostasis
- Mitochondrial dysfunction
- Glucose intolerance
- Insulin sensitivity
- Cellular senescence
- Altered epigenetics
This is partly because NAD+ plays a role in maintaining the stability of the human genome, being capable of repairing its own DNA. As we age, DNA damage occurs when cells divide, which mainly contributes to aging signs and the formation of cancers.
Additionally, NAD+ is required for energy production in much of the body, including the brain, immune cells, and muscle tissue. As NAD+ levels decline with age, these parts of the body begin to lose the efficiency they once had.
NAD+ also activates sirtuins, a class of enzymes that influence aging and longevity by acting within the body. They regulate various metabolic processes, including insulin secretion, lipid mobilization, stress response, and lifespan modulation. They also affect circadian rhythms and mitochondrial biogenesis. These enzymes are activated when NAD+ levels increase.
Chronic inflammation and increased immune activation are key factors responsible for the decline in NAD+ levels in the body. As people age, they are more likely to experience these issues, which may partly explain the apparent decline in NAD+ presence in humans.
Energy Metabolism
NAD+ can be synthesized from various dietary sources, such as salmon, lean meats, legumes, and nuts, but these only provide a small portion of what the human body truly needs. The main source comes from a recycling mechanism known as the salvage pathway.
NAD+ participates in reduction and oxidation processes, often referred to as redox reactions. These convert the oxidized form of NAD (NAD+) into its reduced form NADH—a crucial process for glucose and fatty acid metabolism and ATP formation.
As NAD levels gradually decline with age, this can manifest through the following issues, along with increased risk of neurodegenerative diseases and infections:
- Decreased autophagy
- Increased DNA damage
- Increased mitochondrial dysfunction
- Metabolic imbalance
However, there are things people can do to increase the amount of available cellular NAD+, and these actions are entirely independent of age:
- NAD+ increases during fasting and exercise.
- Increased NAD+ levels in animal studies have been associated with longer lifespan in those animals.
There are several practices that can have a practical effect on NAD+ levels in the body when used in combination:
- Fasting, caloric restriction, and exercise: Activities that cause energy stress in the body are very effective at boosting NAD+ levels.
- Consuming foods high in tryptophan or nicotinic acid are other ways to increase NAD+ levels, although this alone may not produce the profound effect some patients are seeking.
However, because the demand for this molecule is so high within the body, the organism relies on another way to produce it through a recycling system known as the Salvage Pathway. This pathway recycles nicotinamide, which is released when enzymes use NAD+. That nicotinamide is converted into nicotinamide mononucleotide, and then into NAD+. However, this process is subject to feedback inhibition by NAD+ levels in the body, meaning that if NAD+ levels are too high, this recycling process will shut down.
NAD boosters in supplement form can be tolerated at high doses and may effectively raise NAD+ levels. There is also evidence suggesting they help improve conditions associated with aging.
- Published in Blog
The Regenerative Revolution: A New Era in Hair Restoration
The Pursuit of Luscious Locks: Evolution of Hair Restoration
Traditional Hair Transplants: The Old Guard
For decades, methods like Follicular Unit Transplantation (FUT) and Follicular Unit Extraction (FUE) have dominated hair restoration, moving hair follicles from donor areas to balding spots. However, these methods often leave scars and have limited donor hair availability.
Regenerative Medicine: Revolutionizing Hair Restoration
Regenerative medicine is reshaping hair restoration with innovative approaches:
Stem Cell Therapy: Stem cells can differentiate into hair follicles, potentially stimulating hair regeneration and natural growth when introduced into the scalp.
Platelet-Rich Plasma (PRP): Using the patient’s blood enriched with growth factors, PRP therapy revitalizes hair follicles, promoting improved hair growth and quality.
Exosomes: These cellular vesicles aid in hair growth by reducing inflammation and supporting tissue regeneration, creating an optimal environment for follicle health.
Why This Transformation Matters
The shift to regenerative medicine in hair restoration goes beyond aesthetics:
Scar Minimization: Regenerative techniques minimize scarring, leading to more aesthetically pleasing results.
Enhanced Outcomes: Patients often experience more natural, robust hair growth compared to traditional methods.
Personalized Care: Regenerative medicine allows for tailored treatments that address each patient’s specific needs and hair restoration goals.
The Future of Hair Restoration
Hair transplants are undergoing a revolution with regenerative medicine:
The integration of regenerative techniques promises more natural, minimally invasive, and personalized solutions for hair loss.
Embrace the Future of Hair Restoration
Explore the frontier of regenerative medicine in hair restoration with ISSCA. Discover cutting-edge courses and insights shaping the future of healthcare on our website.
- Published in Blog
The Revolution of CAR-NK Therapy: Transforming Disease Treatment
In the ever-evolving landscape of medical innovation, one breakthrough stands out—a transformative approach known as CAR-NK therapy. This groundbreaking development has the potential to revolutionize disease treatment, offering a safer and more effective solution for patients. Join us as we delve into the five pivotal aspects of CAR-NK therapy, reshaping the future of medical care.
CAR-NK Therapy: Why is it a Game-Changer in Disease Treatment
1. Enhanced Safety and Versatility:
At its core, CAR-NK therapy represents a monumental shift in the treatment of various medical conditions. What sets it apart is its enhanced safety and versatility. Unlike its predecessor, CAR-T therapy, which uses the patient’s own T cells, CAR-NK cells can be derived from healthy donors or stem cells. This distinction significantly reduces the risk of complications, including graft-versus-host disease and cytokine release syndrome, which can sometimes accompany CAR-T therapy. Moreover, CAR-NK cells can be stored and used off-the-shelf, making them more readily available for patients in need.
2. Effective Against a Wide Range of Diseases:
The versatility of CAR-NK therapy extends to its effectiveness against a diverse spectrum of diseases. These remarkable cells possess the ability to target multiple antigens present on various cell types. From hematologic conditions to solid tumors, CAR-NK therapy demonstrates remarkable efficacy. Furthermore, it has the potential to counteract the mechanisms employed by cells to evade the immune system, such as immunosuppression and antigen loss.
3. Cost-Efficiency and Speedy Production:
Another compelling aspect of CAR-NK therapy is its cost-efficiency and rapid production. In comparison to the complex and personalized approach required for CAR-T therapy, CAR-NK cells can be manufactured on a larger scale. This streamlined production process significantly lowers costs, making this innovative therapy more accessible to a wider range of patients. The affordability of CAR-NK therapy brings us one step closer to a future where cutting-edge treatments are within reach for all.
4. A Thriving Field with Promising Potential:
While CAR-NK therapy is still in its early stages of clinical development, the initial results are promising and encouraging. Researchers and medical professionals worldwide are working tirelessly to unlock its full potential. Early trials have demonstrated its safety and efficacy, raising hopes for further breakthroughs in disease treatment.
CAR-NK therapy represents a monumental leap forward in disease treatment. At ISSCA.com, we are dedicated to advancing knowledge in the realm of regenerative medicine. We invite you to explore the transformative possibilities of CAR-NK therapy and its potential to reshape the future of medical care. As we journey together, you’ll discover that the horizon of possibilities in healthcare is continually expanding.
Explore our courses and international congresses at ISSCA.com to deepen your knowledge in regenerative medicine.
- Published in Blog
Beyond Boundaries: How Stem Cells Are Reshaping Organ and Tissue Transplantation
Stem Cells: Pioneers of Regeneration
Within the sacred corridors of medical advancement, a profound transformation is silently taking place, poised to reshape the very foundations of organ and tissue transplantation. Envision a realm where donor shortages and the specter of immune system rejection fade into history, and where medical horizons stretch to unprecedented frontiers. In this immersive voyage, we embark on a journey to unmask the enigmatic power of stem cells in the realm of transplantation, a journey that invites you to witness the precipice of medical progress.
The Choreography of Compatibility
Navigating the intricate choreography of compatibility between donor and recipient is one of the most formidable tasks in transplantation. The ever-watchful immune system often triggers rejection, undermining even the most meticulous transplantation endeavors. Yet, stem cells are orchestrating a symphony of change. Through ingenious techniques, researchers are tapping into stem cells’ immunomodulatory prowess, crafting an environment of harmonious coexistence between donor and recipient. This revolutionary approach not only mitigates the risks of rejection but also broadens the spectrum of viable donors.
A Symphony of Science
The harmony between stem cells and transplantation is not an untested hypothesis; it’s a symphony composed through rigorous scientific exploration. An extensive repertoire of peer-reviewed studies, gracing the pages of prestigious journals such as The Lancet and Nature Communications, underscores the potential of stem cells to elevate transplant success rates. These studies illuminate advancements spanning from refining graft survival to hastening the regeneration of vital tissues, a resounding affirmation of the transformative capabilities underpinning stem cell-driven transplantation.
Embark on a Journey of Revelation
Eager to unravel the mysteries encapsulating stem cell-powered transplantation? We extend a heartfelt invitation to embark on an illuminating expedition through our comprehensive training courses in regenerative medicine. Enrich your understanding under the tutelage of eminent experts, delving into the most recent breakthroughs, evidence-based methodologies, and clinical applications. Step into a realm where the boundaries of medical possibilities are redrawn, where your perception of transplantation is enriched, and where you assume the mantle of a pioneer in the regenerative revolution.
The fusion of stem cells and organ transplantation isn’t confined to the realm of scientific speculation; it represents a monumental stride towards re-scripting the destinies of countless lives. As we venture into an epoch where medical accomplishments redefine our limits, the expedition becomes all the more exhilarating.
Join us at issca.us, where the convergence of science and hope awaits. Immerse yourself in the vanguard of regenerative medicine, where the transformative prowess of stem cells beckons. Together, we shall forge ahead, empowered by the symphony of possibilities, shaping a brighter, healthier future for generations to come.
- Published in Blog
Exploring the Frontier of Regenerative Medicine: Unraveling Autologous and Allogeneic Stem Cells
WEDNESDAY, 06 SEPTEMBER 2023 / PUBLISHED IN BLOG
Exploring the Frontier of Regenerative Medicine: Unraveling Autologous and Allogeneic Stem Cells
In the realm of modern medicine, a groundbreaking field has emerged, promising to reshape the way we approach healing and rejuvenation – regenerative medicine. At the heart of this revolution lie stem cells, the unsung heroes of tissue repair and regeneration. In this comprehensive exploration, we delve into the intricate differences between two crucial types of stem cells: autologous and allogeneic. Prepare to be captivated by the scientific intricacies that underpin these extraordinary cells and discover how they’re poised to redefine medical possibilities.
Autologous Stem Cells: A Personalized Touch
Imagine harnessing the power of your body’s own natural healing abilities. Autologous stem cells make this vision a reality. Derived from your own tissues – be it bone marrow, adipose tissue, or other sources – these cells hold the promise of personalized healing. The process involves harvesting the stem cells, processing them to enhance their therapeutic potential, and then reintroducing them into the body. This “self-healing” approach minimizes the risk of rejection and side effects, making autologous stem cell therapies an attractive option for many.
Scientific Precision
Autologous stem cell therapies are supported by a wealth of scientific evidence. Studies published in esteemed journals like the Journal of Translational Medicine and Stem Cell Research & Therapy have highlighted their potential in diverse applications, from musculoskeletal disorders to cardiovascular conditions. This approach holds immense promise for targeted healing while minimizing the risk of immune system complications.
Allogeneic Stem Cells: A Shared Resource for Healing
In the quest for regenerative solutions, allogeneic stem cells emerge as a game-changer. These cells are sourced from carefully screened donors and subsequently administered to patients. By tapping into a shared pool of stem cells, medical practitioners can provide a standardized treatment option that’s readily available. Allogeneic stem cells hold the potential to address a broad spectrum of conditions, offering a versatile and accessible avenue for regenerative therapies.
Scientific Validation
The science behind allogeneic stem cell therapies is compelling. Rigorous research published in renowned journals such as the Journal of Stem Cells and Development and Stem Cells Translational Medicine has underscored their efficacy in various medical scenarios. This approach not only broadens the scope of treatment but also expedites the therapeutic process, presenting an exciting frontier in regenerative medicine.
Embrace the Future with Knowledge
Intrigued by the dynamic interplay of autologous and allogeneic stem cells in regenerative medicine? We invite you to embark on a transformative journey of discovery through our comprehensive training courses. Our platform offers unparalleled insights into the latest advancements, evidence-based practices, and clinical applications of these remarkable stem cells. Guided by esteemed experts in the field, our courses provide a unique opportunity to stay at the forefront of regenerative medicine’s evolution.
As the horizon of medicine expands to encompass regenerative possibilities, autologous and allogeneic stem cells take center stage. These cellular protagonists hold the key to unlocking personalized healing and broad-spectrum rejuvenation, ushering in an era of medical advancement like never before. Join us in our mission to unravel the mysteries of regenerative medicine and explore the profound potential of stem cells. Visit issca.us today, and together, let’s embark on a journey that could reshape the landscape of healthcare for generations to come.
- Published in Blog
Global Stem Cells Group (GSCG) and Dr. Yanti Aesthetic Clinic Elevate Regenerative Medicine Landscape with New Stem Cell Center in Jakarta
Miami, Florida – Global Stem Cells Group (GSCG) is thrilled to announce the grand opening of its latest state-of-the-art Stem Cell Center, located in Jakarta, Indonesia. This momentous occasion marks a significant stride forward in the field of regenerative medicine and showcases GSCG’s commitment to providing innovative healthcare solutions worldwide.
In a groundbreaking partnership with the esteemed Dr. Yanti Aesthetic Clinic, GSCG introduces its third Stem Cell Center in Indonesia, complementing existing facilities in Surabaya and Bandung. Further underscoring their dedication to advancing medical research, GSCG also anticipates the unveiling of a fourth location in Bali in the near future.
The launch of the Stem Cell Center in Jakarta serves as a beacon of innovation, the International Society for Stem Cell Application (ISSCA), GSCG’s educational division, conducted a groundbreaking training session alongside Dr. Alan Gaveck. This session spotlighted the transformational potential of NK cell therapies in treating Cancer and Anti-aging concerns, further cementing GSCG’s pioneering influence.
A distinctive feature of this collaboration is the authorization granted to Dr. Yanti Aesthetic Clinic to leverage GSCG’s brand, technologies, products, and treatment protocols. Operating as a franchise, the center proudly carries the brand, adhering to meticulous organizational guidelines, while being owned and operated by Dr. Yanti Aesthetic Clinic. This symbiotic arrangement seamlessly merges shared expertise with individual ownership, fostering a harmonious blend of vision and innovation.
Beyond its role as a clinical hub, the newly inaugurated Stem Cell Center will also serve as a focal point for ISSCA’s training initiatives in Asia. In addition to the pioneering NK cell therapy training conducted at the clinic, the center will facilitate educational programs to empower medical professionals across the continent with cutting-edge insights and advancements in regenerative medicine.
Benito Novas, an esteemed figure in the realm of regenerative medicine and the head of Public Relations for GSCG and ISSCA, shared his insights during the inaugural event, stating, “Global Stem Cells Group is dedicated to democratizing regenerative medicine access on a global scale. We encourage physicians to embrace the clinical and aesthetic applications of stem cell therapy, enabling patients around the world to experience the transformative benefits of regenerative treatments.”
Reflecting on the journey that led to this momentous occasion, Novas continued, “Dr. Yanti and I met in Brussels back in 2018, when this ambitious endeavor was but a vision. Today, as we witness the fruition of that vision, I express my profound gratitude for the privilege of collaborating with Dr. Yanti Aesthetic Clinic in ushering in the future of regenerative medicine.”
Dr. Yanti Kushmiran, Director of the DR. Yanti Aesthetic Clinic, echoed these sentiments, stating, “Our partnership with GSCG, a trailblazer with over a decade of pioneering work, resonates deeply with our commitment to excellence. The establishment of our third Stem Cell Center in Indonesia under the esteemed Global Stem Cells Group brand strengthens our ability to provide enhanced services to our patients, ushering in a new era of regenerative healthcare.”
With the inauguration of the Stem Cell Center in Jakarta, GSCG and Dr. Yanti Aesthetic Clinic take a significant stride towards advancing regenerative medicine’s frontiers. This landmark collaboration is poised to shape the future of medical care, leveraging cutting-edge technologies and expertise to benefit patients across the Asian continent and beyond.
About Dr. Yanti Aesthetic Clinic:
Dr. Yanti Aesthetic Clinic is a revered healthcare institution renowned for its state-of-the-art aesthetic and regenerative treatments. With an unwavering dedication to excellence and a forward-thinking approach, Dr. Yanti Aesthetic Clinic is poised to shape the future of regenerative medicine in Indonesia and beyond.
About the International Society for Stem Cell Application (ISSCA):
The International Society for Stem Cell Application (ISSCA) serves as the educational arm of Global Stem Cells Group (GSCG), dedicated to promoting knowledge and expertise in stem cell therapy and regenerative medicine. ISSCA empowers medical professionals across the globe with essential insights and advancements in the field.
About Global Stem Cell Group
The Global Stem Cell Group is a family of several companies focused on stem cell medicine and research. The company uses its network to bring leadership in regenerative medicine training, research, and patient applications.
GSCG’s mission is to allow physicians to present the benefits of stem cell medicine to patients worldwide. The company also partners with policymakers, educators, and regulators to promote regenerative medicine.
Global Stem Cells Group is a publicly traded company operating under the symbol MSSV. https://finance.yahoo.com/quote/mssv/
To learn more about Global Stem Cells Group, Inc.’s companies visit our website www.stemcellsgroup.com or call +1 305 560 5331
Safe Harbor Statement: Statements in this news release may be “forward-looking statements”. Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions, or any other information relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates, and projections about our business based partly on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual outcomes and results may and are likely to differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release, and The Global Stem Cells Group undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release. This press release does not constitute a public offer of any securities for sale. Any securities offered privately will not be or have not been registered under the Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.
- Published in News
Advancements in Hair Transplantation: A Paradigm Shift in Regenerative Medicine
WEDNESDAY, 09 AUGUST 2023 / PUBLISHED IN BLOG
In the realm of regenerative medicine, hair transplantation has experienced remarkable progress in recent years. As part of a multidisciplinary community of physicians and scientists dedicated to advancing the field, it is essential to stay informed about the latest developments in this area. This blog post aims to provide a comprehensive overview of the cutting-edge advancements in hair transplantation, highlighting the convergence of science, technology, and practice.
Tissue Engineering in Hair Transplantation
The integration of tissue engineering principles into hair transplantation has opened new avenues for regenerative medicine. Scientists are actively exploring the use of biomaterials, growth factors, and scaffolds to create an optimal environment for transplanted hair follicles. By nurturing follicular cells, tissue engineering techniques hold immense potential in enhancing transplantation outcomes and promoting tissue regeneration.
Stem Cell-Based Approaches
Stem cell therapy has emerged as a promising strategy within the realm of hair transplantation. Researchers are investigating the utilization of mesenchymal stem cells (MSCs) and adipose-derived stem cells (ADSCs) to stimulate hair follicle regeneration. These unique regenerative cells promote hair growth and significantly enhance the success rate of transplantation procedures. Ongoing research in stem cell-based therapies continues to unveil their potential to revolutionize hair restoration techniques.
Gene Therapy for Hair Loss
Gene therapy is gaining traction as a cutting-edge approach to addressing hair loss at its core. Scientists aim to develop innovative treatments for both genetic and acquired forms of hair loss by manipulating genes involved in hair growth and regulation. Techniques such as CRISPR-Cas9 gene editing hold immense potential for altering gene expression associated with hair follicle development, offering personalized regenerative therapies.
Nanotechnology in Hair Transplantation
Nanotechnology has paved the way for groundbreaking advancements in hair transplantation. Researchers are exploring the application of nanomaterials and nanoparticles to enhance the targeted delivery of growth factors, drugs, and stem cells directly to the hair follicles. This precise and controlled release optimizes the regenerative potential of transplanted hair follicles, leading to improved treatment outcomes and faster healing.
Artificial Intelligence (AI) and Machine Learning
The integration of AI and machine learning algorithms has transformed various medical fields, including hair transplantation. AI-powered technologies assist in precise hair follicle extraction, optimizing graft placement, and predicting post-transplant outcomes. By analyzing vast datasets and patterns, AI algorithms enhance decision-making, improve surgical techniques, and contribute to personalized treatment plans in hair transplantation.
As active contributors to the advancement of regenerative medicine, staying informed about the latest developments in hair transplantation is crucial. Tissue engineering, stem cell-based approaches, gene therapy, nanotechnology, and the integration of AI and machine learning are reshaping the landscape of hair restoration. By remaining at the forefront of these advancements, physicians and scientists can harness the power of regenerative medicine to effectively treat hair loss and alleviate human suffering.
Join us at issca.us and let us continue to collaborate, innovate, and explore the limitless potential of regenerative therapies.
- Published in Blog
Global Stem Cells Group Announces New President of the International Society for Stem Cell Application (ISSCA)
Miami, Florida – Global Stem Cells Group, a leading organization in the field of regenerative medicine, is pleased to announce the appointment of Dr. Salih Yildirim as the new President of the International Society for Stem Cell Application (ISSCA), a division of Global Stem Cells Group. Dr. Yildirim previously held the position of Director of Overseas Operations at ISSCA.
Dr. Salih Yildirim brings a wealth of experience and expertise to his new role as President of ISSCA. Having previously served as the Director of Overseas Operations, Dr. Yildirim has demonstrated his exceptional leadership skills and strategic vision throughout his career. He has played a vital role in expanding ISSCA’s international presence and fostering collaborations with stakeholders worldwide.
In a statement regarding the appointment, Dr. Daeyong Kim, the former President of ISSCA, expressed his confidence in Dr. Yildirim’s ability to lead the organization. Dr. Kim stated, “I think you are the best leader and the most prepared to be the President of ISSCA. Therefore, I think you should be the head of ISSCA.” Dr. Kim will now transition to other support functions within ISSCA.
Benito Novas, head of Public Relations for ISSCA, expressed his admiration for Dr. Salih Yildirim’s professional qualities. Novas said, “I have known and worked with Dr. Salih for more than 10 years, and I am honored to have him as President within the company. During these years, he has proven to be an exceptional leader with a great vision for ISSCA.”
ISSCA’s objectives under the leadership of Dr. Salih Yildirim will include advancing the understanding and application of stem cell therapies, promoting scientific research and collaboration among professionals in the field, and advocating for the ethical and responsible use of regenerative medicine worldwide. Dr. Yildirim’s extensive experience in business development, international relations, and regenerative medicine will undoubtedly contribute to the achievement of these objectives.
About Dr. Salih Yildirim:
Dr. Salih Yildirim holds a bachelor’s and master’s degrees in business administration from Cleveland State University (United States) and a Ph.D. in health management from the University of Health Sciences. He has held various key positions throughout his career, including Director of Overseas Operations at ISSCA. Dr. Yildirim is currently the General Manager of BioTrend Medical International, a biotechnology firm specializing in genetics, molecular biology, and stem cell technologies. He also serves as the chief executive officer of ReGen.IC Clinic, specializing in regenerative medicine and stem cell applications. Additionally, he is a member of the International Society for Stem Cell Application’s Board of Directors and the Global Stem Cell Group’s Board of Directors and International Operations Manager. Dr. Yildirim is also a member of Istanbul Atlas University’s Board of Directors. He is married and a proud father.
About ISSCA
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians who aspire to treat diseases and lessen human suffering through advances in science, technology, and regenerative medicine.
ISSCA updates its members on advances in stem cell research, MSC, exosomes, and regenerative medicine
The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.
The international community provides a platform for practitioners to interact with scientists and build medical networks necessary for marketing.
As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities worldwide. The goal is to encourage more physicians to practice regenerative medicine and make it available to patients nationally and internationally. Incorporated under the Republic of Korea as a non-profit company, the ISSCA is focused on fostering excellence and standards in regenerative medicine.
About Global Stem Cells Group
Global Stem Cells Group is the parent company of six companies that are dedicated to stem cell research, solutions, and technology training. The group was founded in 2012 and combines dedicated researchers, patient educators, and physician trainers with the shared goal of meeting the need for high-end stem cell solutions and treatments.
Given that the group has a singular focus in this field, it is uniquely positioned to become the global leader in cellular medicine. In addition, by bringing together leading professionals in cellular medicine, it can discover issues that the industry faces and focus its research and development in this area. This specialization has, undoubtedly, enabled it to come up with solutions that address some of the significant issues that most stakeholders are facing in the industry.
Global Stem Cells Group is a publicly traded company operating under the symbol MSSV. https://finance.yahoo.com/quote/mssv/
Safe Harbor Statement: Statements in this news release may be “forward-looking statements”. Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions, or any other information relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates, and projections about our business based partly on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual outcomes and results may and are likely to differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release, and The Global Stem Cells Group undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release. This press release does not constitute a public offer of any securities for sale. Any securities offered privately will not be or have not been registered under the Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.
- Published in News
International Society for Stem Cell Applications Launches Advanced Turkish Hair Transplant Certification Program in Cancun
Miami, Florida – The International Society for Stem Cell Applications (ISSCA) is thrilled to announce the launch of its newest program, the Advanced Turkish Hair Transplant Certification. This pioneering training and certification initiative will take place from December 8th to 10th at the prestigious Cellular Hope Institute Facility in Cancun, Mexico. Physicians are encouraged to register promptly as the program is expected to fill up quickly.
Turkey has earned a global reputation for providing the finest hair transplants worldwide. Some of the hair transplant experts from Turkey who have developed and perfected this procedure are now willing to share their secrets with any physician who seeks to excel in hair restoration procedures in their home country. The demand for hair regrowth, hair restoration, and hair transplant procedures is growing by the day as men and women realize they do not have to suffer from the embarrassment of thinning hair and bare scalps anymore.
The Advanced Turkish Hair Transplant Certification program offers a comprehensive curriculum encompassing cutting-edge hair transplant procedures. Participants will engage in both theoretical and practical training sessions, helping to assist their mastery of this rapidly expanding field. They will have the extraordinary opportunity to practice hair transplant surgeries under the supervision and guidance of world-renowned experts in the field, including Veysel Cabalar, Asli Uslu, and Emere Tuncinar, who bring their wealth of experience and knowledge to the program.
In addition to hair transplant surgery, the program’s curriculum will cover workshops on advanced hair restoration techniques such as exomes, stem cells, and platelet-rich plasma treatments. Participants will learn how to select suitable patients for these different hair restoration methods and gain hands-on experience in preparing, storing, and administering exosomes, stem cells, and platelet-rich plasma to promote hair regrowth. Armed with this expertise, we believe participants will return to their own clinics with confidence, ready to deliver these transformative procedures for the benefit of their patients.
Dr. Salih Yildirim, ISSCA President, expressed his delight in fulfilling the organization’s mission of expanding the reach of new regenerative medicine technologies to doctors and patients worldwide: “The Advanced Turkish Hair Transplant Certification program exemplifies our commitment to advancing the field of regenerative medicine. We are proud to provide doctors with the tools and knowledge to bring the latest hair restoration techniques to their patients.”
Benito Novas, ISSCA Vicepresident , added, “We are excited to bring this groundbreaking Turkish training to Cancun, offering local doctors and physicians across Latin America the opportunity to learn from the best. Our collaboration with the Cellular Hope Institute Facility underscores our dedication to providing exceptional educational experiences that benefit medical professionals and patients alike.”
The program will include theoretical sessions on scalp and hair follicle anatomy, patient evaluation, and surgical preparation for hair transplant procedures. Detailed workshops on graft extraction and implantation techniques will also be conducted, enabling participants to refine their skills and achieve realistic, outstanding results. From patient evaluations to postoperative care protocols, the hands-on surgical sessions will encompass every aspect of the hair transplant process.
The Advanced Turkish Hair Transplant Certification program by ISSCA offers an invaluable opportunity for doctors seeking to excel in the field of hair transplantation. Participants will gain comprehensive knowledge, refine their surgical techniques, and stay abreast of the latest advancements in hair regrowth, hair restoration, and hair transplants.
To learn more about the Advanced Turkish Hair Transplant Certification program and register for this transformative educational experience, please visit the official ISSCA website at www.issca.com.
About ISSCA
The International Society for Stem Cell Applications (ISSCA) is a multidisciplinary community of scientists and physicians collaborating to treat diseases and lessen human suffering through advances in regenerative medicine. By bringing together worldwide researchers and healthcare practitioners, ISSCA aims to bridge the gap between cutting-edge scientific research and compassionate, effective patient care.
About Global Stem Cells Group
Global Stem Cells Group (GSCG) is a world-renowned leader in regenerative medicine, specializing in innovative solutions that harness the power of stem cells for therapeutic applications. With a global network of offices and an unwavering commitment to excellence, GSCG continues to shape the future of regenerative and restorative medicine through groundbreaking products and advanced treatment protocols.
Global Stem Cells Group is a publicly traded company operating under the symbol MSSV. https://finance.yahoo.com/quote/mssv/
Safe Harbor Statement: Statements in this news release may be “forward-looking statements”. Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions, or any other information relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates, and projections about our business based partly on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual outcomes and results may and are likely to differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release, and The Global Stem Cells Group undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release. This press release does not constitute a public offer of any securities for sale. Any securities offered privately will not be or have not been registered under the Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.
- Published in News
ISSCA Announces Its Next World Congress 2023: The Premier Regenerative Medicine Event of the Year
The International Society for Stem Cell Application (ISSCA) is excited to announce the much-anticipated World Congress 2023, further establishing its role as the primary global hub for regenerative medicine. The event is set to occur from November 10 to 12, 2023, at the esteemed Crowne Plaza Istanbul Florya Hotel in Istanbul, Turkey. Drawing on the remarkable achievements of the previous conference held at the Radisson Blu Hotel on September 23 to 26, 2022, ISSCA is prepared to exceed all predictions with this highly anticipated World Congress.
During the three-day congress, prominent physicians from across the globe will come together, offering an extensive agenda of presentations and interactive sessions. “Our ISSCA Congresses once more provide a great opportunity to disseminate this information to the physicians who need it most, and we plan to organize as many as we can before the end of the year,” says ISSCA Managing Director and CEO of Global Stem Cells Group Benito Novas about the upcoming congress.
Participants can anticipate captivating workshops, including those focused on aesthetic and clinical applications, aimed at delving into the most recent advancements within the rapidly evolving field of regenerative medicine.
In a full schedule of lectures, the congress will shed light on significant subjects such as molecular biology, innovative treatment approaches in surgical and cosmetic domains, and the latest cutting-edge technologies that have emerged in the field. In addition, the congress will explore the legal framework encompassing regenerative medicine practices on a global scale, acknowledging the varying degrees of involvement by various national governments.
This conference demonstrates ISSCA’s dedication to facilitating a transformative change from traditional healthcare methods to regenerative medicine while showcasing the most recent innovative discoveries and progress in all aspects of stem cell research.
The Crowne Plaza Istanbul Florya Hotel, known for its modern facilities and ideal location in Istanbul, Turkey, will serve as the prestigious venue for this highly anticipated event. Its comfortable and conducive environment provides the optimum platform for attendees to exchange ideas and establish new partnerships.
The ISSCA World Congress 2023 in Istanbul is a must-attend event for anyone interested in regenerative medicine. With a focus on innovation, collaboration, and knowledge exchange, the congress promises to be a transformative experience for all attendees. Whether you are a scientist, physician, or healthcare professional, this event offers an opportunity to gain valuable insights and forge new connections with like-minded individuals from around the world.
For more information about the November 10 to 12 ISSCA World Congress 2023, please visit our official website today.
About ISSCA:
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians who aspire to treat diseases and lessen human suffering through advances in science, technology, and the practice of regenerative medicine. ISSCA serves its members through advancements made in the specialty of regenerative medicine.
The mission of the International Stem Cell Certification Agency (ISSCA) is to establish itself as a global leader in regenerative medicine certification, education, research, and training.
ISSCA provides certification training in cities worldwide because it recognizes the importance of standards and certifications in regenerative medicine as a medical specialty. To help more people, both locally and globally, as the demand for more doctors interested in and comfortable with regenerative medicine surges. ISSCA’s mission is to advance quality and uniformity in regenerative medicine worldwide.
About Global Stem Cells Group:
The Global Stem Cell Group is a family of several companies focused on stem cell medicine and research. The company uses its network to bring leadership in regenerative medicine training, research, and patient applications.
GSCG’s mission is to allow physicians to present the benefits of stem cell medicine to patients worldwide. The company also partners with policymakers, educators, and regulators to promote regenerative medicine.
Global Stem Cells Group is a publicly traded company operating under the symbol MSSV. https://finance.yahoo.com/quote/mssv/
To learn more about Global Stem Cells Group, Inc.’s companies visit our website www.stemcellsgroup.com or call +1 305 560 5331
Safe Harbor Statement:
Statements in this news release may be “forward-looking statements”. Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions, or any other information relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates, and projections about our business based partly on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual outcomes and results may and are likely to differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release, and The Global Stem Cells Group undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release. This press release does not constitute a public offer of any securities for sale. Any securities offered privately will not be or have not been registered under the Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.
- Published in News
